News

14/07/2021

The acquisition of Luminex Corporation represents an important step in the expansion strategy of DiaSorin…
Read the press release

12/07/2021

Integrated Symposium Diagnosis and immune response of SARS-CoV-2 infection, Flash session TrimericS IgG serology assay in heterologous vaccination.
Register to access

08/02/2021

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 TrimericS IgG assay, a new quantitative serology test for determination of IgG antibodies against SARS-CoV-2.
Read the press release